Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colitis, Ulcerative 3Arthritis, Rheumatoid 3Spondylitis, Ankylosing 1Recurrence 1Prostatic Neoplasms 1Lymphoma 1Inflammatory Bowel Diseases 1Diabetes Mellitus, Type 1 1Crohn Disease 1

Interventions

Adalimumab 5tocilizumab 1secukinumab 1golimumab 1Vaccines 1Tumor Necrosis Factors 1Tai Ji 1Sulfasalazine 1Sodium Chloride 1Saline Solution 1Pamidronate 1Meloxicam 1Herpes Zoster Vaccine 1Exercise 1Etoricoxib 1Etanercept 1Celecoxib 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Spondylitis, Ankylosing × golimumab × Clear all
NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡